ArticleJournal of cytology
Institutional Study on Unsatisfactory Pap Smears: Causes and Clinical Impact.
Article in Journal of cytology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Cervical cancer screening using cervical Papanicolaou (Pap) smears has been well established since the mid-20th century. Specimen adequacy is considered the most relevant quality assurance component since the invention of the Bethesda system for reporting cervical cytology. Cervical smears that are reported as unsatisfactory (US) can significantly delay diagnosis and increase the risk of cancer in follow-up tests. They also lead to unnecessary use of resources. Materials and Methods: The cases signed out as US for one and half year duration in the cytology laboratory were retrieved, and demographic details were collected. Results: Among the 4,139 Pap tests accepted and reported for the period, 240 (5.8%) were signed out as US. The ratio of conventional to ThinPrep smears was 2.4:1. 70% cases were conventional Pap smears. 66% (159/ 240) cases of the patients were in the fourth and fifth decade age group. Low squamous cellularity was the most common cause (80%) of US smears, obscured by inflammation (12%); other causes were obscuration by blood (0.8%) and mucus (0.4%), drying artifacts (1.6%) and cytolysis (0.4%). Discussion and Conclusion: US smears largely depend on various factors, that is, the expertise of the person taking a sample, the date of collection in the menstrual cycle, the method of sampling, sampling devices and staining procedures. The variability in sample collection, including occasional collection by personnel with inadequate training, may also have contributed to the US smears. The result of our study is expected to have a significant impact on proper sampling and the use of adequate quality control measures. In addition, through our follow-up data, we could emphasize the importance of follow-up and human papilloma virus co-testing in patients with US smears.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.